Barinthus Biotherapeutics (BRNS) Earnings Date & Reports

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BRNS is expected to report earnings to rise 100.00% to -28 cents per share on August 06

Barinthus Biotherapeutics BRNS Stock Earnings Reports

Q2'26

Est.

$-0.28

Q1'26

Beat

by $0.18

Q4'25

Beat

by $0.11

Q3'25

Beat

by $0.04

Q2'25

Missed

by $0.16

The last earnings report on May 01 showed earnings per share of -14 cents, beating the estimate of -31 cents. With 54.69K shares outstanding, the current market capitalization sits at 28.51M.

View a ticker or compare two or three

Compare

BRNS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BRNS